background: breast cancer (bc) is the second most commonly diagnosed cancer after lung cancer. survival of bc patients is affected by intermediate events. this study was aimed to investigate the disease course of primary non-metastatic bc patients with first recurrence of the tumor (frt) as the intermediate event using the illness- death model. methods: this retrospective cohort study was condu...

Investigating nozzle’s orifice flow is challenging both experimentally and theoretically. This paper focuses on simulating flow inside diesel injector nozzle via Ansys fluent v15. Validation is performed with experimental results from Winkhofler et al (2001). Several important parameters such as mass flow rate, velocity profiles and pressure profiles are used for this validation. Results includ...

Introduction The United Kingdom's Department for Education's advice on behaviour focuses the power of staff and strength policy in challenging behaviour, via rules, sanctions rewards. We designed a video-feedback intervention teams special educational setting who were working with children intellectual disability behaviour. aimed to raise reflective capacity relational mechanisms that offer new...

Introduction: In radiotherapy with external surrogates, exact information of tumor position is one of the key factors that improves treatment delivery. Many dynamic tumors in thorax region of patient move mainly due to respiration and are known as intra-fractional motion error that must be compensated, as well. One of clinical strategy is using Stereotactic Body Radiation Thera...

The brain tumor, the most common and aggressive disease, leads to a very shorter lifespan. Thus, planning treatments is crucial step in improving patient's quality of life. In general, several image techniques such as CT, MRI, ultrasound have been used for assessing tumors prostate, breast, lung, brain, etc. Primarily, MRI images are applied detect during this work. enormous amount data produce...

Because of its heterogeneity, lack of prognostic markers, tumor-escape mechanisms, and frequent relapse upon surgical intervention, treatment of hepatocellular carcinoma (HCC) remains challenging. In this issue of Clinical Cancer Research, Groß and colleagues characterize a rodent model that might help identify novel drugs for combinatorial sorafenib-based therapies for HCC.